Exact Sciences
EXAS
#1384
Rank
S$17.04 B
Marketcap
$92.26
Share price
2.34%
Change (1 day)
-10.31%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of June 2024 : S$4.15 B

According to Exact Sciences's latest financial reports the company has S$4.15 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$S$4.15 B1.82%
2022-12-31$S$4.07 B-10.7%
2021-12-31$S$4.56 B54.58%
2020-12-31$S$2.95 B-3.94%
2019-12-31$S$3.07 B231.69%
2018-12-31$S$0.92 B33.27%
2017-12-31$S$0.69 B43.44%
2016-12-31$S$0.48 B4.86%
2015-12-31$S$0.46 B21.2%
2014-12-31$S$0.38 B122.68%
2013-12-31$S$0.17 B42.12%
2012-12-31$S$0.12 B11.58%
2011-12-31$S$0.10 B5.21%
2010-12-31$S$0.10 B1100.14%
2009-12-31$S$8.56 M-344.78%
2008-12-31$-S$3.5 M-138.48%
2007-12-31$S$9.09 M-60.36%
2006-12-31$S$22.93 M-44.05%
2005-12-31$S$40.99 M-26.81%
2004-12-31$S$56 M169.12%
2003-12-31$S$20.81 M-68.72%
2002-12-31$S$66.54 M-39.04%
2001-12-31$S$0.10 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
S$0.96 B-76.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.47 B-64.52%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.37 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$101.92 B 2,351.21%๐Ÿ‡ซ๐Ÿ‡ท France